glp-1 allergy Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports - JDDonline Possible Link Between GLP-1 RA
Description
De ongemakkelijke vraag: moet je dan voor altijd doorgaan
NICE guidance (NG28 for type 2 diabetes, TA875 for semaglutide 2.4 mg, and TA664 for liraglutide 3 mg) recommends regular monitoring of patients on GLP-1 therapy, with particular attention to tolerability and adverse effects
Across 37 studies including 9,341 adults, weight increased by an average of 0.4 kg per month after stopping weight management drugs
the posts analyzed were dated between May 2019 and June 2025
Mounjaro is FDA-approved for type 2 diabetes management, not weight loss
